MSR1 and metabolic dysfunction-associated steatotic liver disease: Foamy macrophage generation and fibrosis was also impeded in mice lacking MSR1, indicating potential therapeutic benefit in non-alcoholic fatty liver disease (NAFLD) (76) and other inflammatory diseases, such as atherosclerosis, where foam cells contribute to pathogenesis (121).